Gyre Therapeutics Inc (GYRE)

R&D to Revenue

65.75%

Quarterly · Period ending:

GYRE logo

GYRE R&D to Revenue

Latest reported65.75%
GYRE Quarterly R&D/Revenue (1679.59% → 65.75%)
High-resolution chart · PNG

GYRE r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
65.7482%
29.9214%
12.9453%
7.7313%
28.0857%
14.0312%
13.318%
10.8875%
13.3003%
8.0303%
16.8263%
9.3908%
12.1654%
10.5692%
21.8347%
21.5392%
0%
1,207.8086%
661.2705%
881.5572%
1,355.477%
1,159.7137%
714.4756%
1,371.6685%
778.4077%
81.0461%
0%
0%
0%
0%
-137,316.6667%
0%
0%
62,850%
1,119.8113%
1,196.5409%
3,063.964%
760.5166%
4,383.0986%
3,115.5963%
2,524.7706%
2,097.2477%
1,620.1835%
1,363.3028%
42.6077%
306.6865%
-713.2733%
-46,308%
-24,511.1111%
10,436.7816%
11,563.4409%
0%
0%
235.2941%
2,091.5254%
837.7604%
37.1883%
77.8799%
137.6036%
134.2337%
97.3099%
60.3093%
95.714%
79.4981%
67.5629%
54.3447%
292.007%
76.0088%
390.424%
154.6165%
163.6237%
-0.1138%
-0.1252%
-0.0979%
278.7481%
0.3018%
0.3195%
301.7925%
28.1504%
0.5306%
779.7047%
0.7855%
2,364.0432%
1,840.4129%
2,432.1199%
1,679.5916%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.